Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (19 quarters reported)
$105M in Q4 2021 → $26.6M now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Autolus Therapeutics PLC | 100.0% | Unchanged | 16,640,720 | $26.6M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 07, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Century Therapeutics | Exited | −1,213,056 | −$2.74M | — |
quarter ended March 31, 2026 · filed May 14, 2026
No position changes this quarter.
quarter ended December 31, 2025 · filed February 05, 2026
No position changes this quarter.
quarter ended September 30, 2025 · filed November 06, 2025
No position changes this quarter.
quarter ended June 30, 2025 · filed August 07, 2025
No position changes this quarter.
quarter ended March 31, 2025 · filed May 07, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Achilles Therapeutics PLC | Exited | −11,086,909 | −$12.6M | — |
quarter ended December 31, 2024 · filed February 06, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Autolus Therapeutics PLC | Trimmed | −1,913,904 | −$4.5M | 73.8% |
quarter ended September 30, 2024 · filed November 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Autolus Therapeutics PLC | Trimmed | −2,792,205 | −$10.1M | 83.4% |
| Century Therapeutics | Added | +212,285 | +$363K | 2.6% |
Loading...
